HomeTNXP • NASDAQ
add
Tonix Pharmaceuticals Holding Corp
Previous close
$14.19
Day range
$14.93 - $16.14
Year range
$13.07 - $69.96
Market cap
211.40M USD
Avg Volume
329.18K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 5.39M | 108.75% |
Operating expense | 52.62M | 120.35% |
Net income | -46.91M | -112.19% |
Net profit margin | -870.32 | -1.64% |
Earnings per share | -3.98 | 60.87% |
EBITDA | -47.80M | -117.42% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 207.64M | 110.21% |
Total assets | 277.17M | 70.16% |
Total liabilities | 32.02M | 37.24% |
Total equity | 245.15M | — |
Shares outstanding | 13.41M | — |
Price to book | 0.74 | — |
Return on assets | -45.59% | — |
Return on capital | -50.51% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -46.91M | -112.19% |
Cash from operations | -39.65M | -171.02% |
Cash from investing | -1.02M | -33,933.33% |
Cash from financing | 59.14M | -30.55% |
Net change in cash | 18.46M | -73.84% |
Free cash flow | -23.09M | -211.17% |
About
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project. Wikipedia
Founded
2007
Headquarters
Website
Employees
142
